Home
Objectives
Conference theme
Participants profile
Abstracts
Venue
Programme Committee
Supported by
Contacts

Neither the European Commission nor any person acting on its behalf is liable for any use of information contained in this publication.

 

 

Programme
Correlation Conference:

Getting out of the margins in Europe –
changing realities and making the difference


Monday, 12 December 2011
15.00

Welcome and introduction

Eberhard Schatz, Correlation Network
>>> Download pdf

15.10

Welcome

  • Hans Wijnands, General Director De Regenboog Groep, Netherlands
    >>> Download pdf
  • Mojca Gobeck, Director General of the Directorate for Public Heath, Ministry of Health, Slovenia
  • Prof. Brigita Drnovsek,Clinic for Infectious Diseases and Febrile Illness, University Medical Centre Ljubljana, Slovenia
  • Eli Zamernik, STIGMA Foundation, Ljubljana
    >>> Download pdf
15.30

Challenges for good policy making

Dr. Chris Tyler
Executive Director, Centre for Science and Policy, University of Cambridge, United |Kingdom
>>> Download pdf

Discussant: Jean Paul Grund, Senior researcher, Center for Addictology, Charles University Prague, Czech Republic

16.15 Break
17.00

Round table discussion:
The impact of Europe on local and national policies targeting marginalised groups

Chair: Carel Edwards
Former Head of the EC's Anti-Drug Coordinating Unit

Panel:
Maurice Galla, European Comission (DG Justice), Belgium
Sascha Marschang, EPHA, Belgium
Lidija Kristančič, Ministry of Health, Slovenia
Jelena Jankovic, Institute for Public Health, Serbia
Liisa Kok, Ministry of Health, Netherlands
Ramazan Salman, Ethno Medical Centre, Germany
Efriede Steffan, SPI/Bordernet, Germany
Anke van Dam, AFEW, Netherlands
Fabrice Olivet, ASUD, France

18.00 Conclusion, Technical Issues
18.30 Reception

Tuesday, 13 december 2011
9.30

Major session I: HIV/AIDS in Europe: challenging political leadership

Chair:
Wolfgang Philipp, European Commission, DG Sanco, Luxembourg
Martine De Schutter, Civil Society Forum on HIV/AIDS, EATG

  • "A focused response to HIV in Europe: setting up policy recommendations to tackle health inequalities in Europe"
    >>> Download pdf

    The Correlation policy recommendations were developed to inform policy making in Europe, both at national level and at EU level, with a view to reducing existing HIV/AIDS-related health inequalities. Drawing on community-level experience, the policy recommendations focus on the HIV epidemiology affecting the four risk groups, the adequacy of current policies and programmes, and the implications and recommendations for policy makers at the national and EU levels.
    Bryan Teixeira, NAZ Project, United Kingdom


  • "The things we do for ... People Living with and vulnerable to HIV: the EU communication on HIV/AIDS (2009-2013) – Where do we stand? Where do we go?" –
    >>> Download pdf
    The EU communication on HIV/AIDS (2009-2013), the second of its kind, provides the blue-print for EU action to combat HIV/AIDS in the EU and the neighbouring countries. The policy principles embedded therein also provide guiding principles for national responses and national collaboration in the EU as well as for neighbouring countries. Findings of the ECDC monitoring review and discussion on how we can link the policy recommendations to this EU communication and a possible new EU communication.

    Wolfgang Phillip, Policy Coordinator HIV/AIDS, European Commission


  • "Making a difference – civil society and the HIV response" – Panel Discussion
    >>> Download pdf
    Given the current economic and political climate and despite past success and advancements in the HIV response in Europe, the HIV response across Europe is at risk of undergoing a sever backlash in the upcoming years.
    Based on the Correlation recommendations and the gaps in the EU response identified in the previous session, the aim is to strategize long term how the HIV response in Europe could be invigorated engaging national policy makers and enhancing collaboration among them, but also creating synergies between the European and the Global HIV response. This will include identifying major advocacy opportunities for HIV in the upcoming years and identifying major partners and social movements the HIV movement could link up to.

    Martine De Schutter (CSF co-chair), Ferenc Bagyinszky (EATG chair), Ninoslav Mladenovic (EATG PWG member)
    session organised by EATG

Major session II: Hepatitis C in Europe – a huge burden and still neglected
Chair: Jeffrey V. Lazarus, Copenhagen University, Denmark

  • Drug user perspective: experiences with Hepatitis C
    >>> Download pdf
    Joost Brantas, Netherlands
    Eli Zamernik, Stigma, Slovenia


  • ECDC-EMCDDA guidance to prevent and control infectious diseases among people who inject drugs
    >>> Download pdf
    Seven interventions, one aim: no infections among people who inject drugs. In a new guidance document Prevention and control of infectious diseases among people who inject drugs, EU agencies ECDC and the EMCDDA have joined forces to identify seven interventions to reduce and prevent infectious diseases in this vulnerable population. Many European countries have achieved substantial progress in recent years in preventing drug-related infections. Drug injecting, however, remains a major cause of infectious diseases across Europe. The interventions proposed range from the supply of injection equipment, testing and vaccination to the treatment of infections and drug dependence. With this report, the two agencies aim to support countries across Europe in their efforts to reduce infection risks.

    Dagmar Hedrich, Head of the 'health and social responses sector' , European Monitoring Centre for Drugs and Drug Addiction
    Mika Salminen, Head of Health Impact Section, European Centre for Disease Prevention and Control
  • Management of HCV infection in drug users: Experiences from Slovenia
    The presentation will describe the the Slovenian National Consensus Guidelines for the management of Hepatitis C virus infection in drug users, the national healthcare network and the evaluation of the results of the interventions in Slovenia.

    Mojca Matičič, Clinic for Infectious Diseases and Febrile Illness, University Medical Centre Ljubljana, Slovenia


  • HCV prevention for young drug users –
    first results of a European study

    >>> Download pdf

    The presentation will present preliminary results of a study, identifying approaches for the prevention of Hepatitis C among in particular young drug users. A main part of the project was to evaluate how drug users manage to remain negative for HCV.

    Heike Zurhold, ZIS, Hamburg, Germany


11.00 Break
11.30 Skill Building workshops
 

Skill building I: Meaningful Peer Involvement
>>> Download pdf
Peer involvement and user participation are 'hot'. But reality shows that starting an initiative is quite a challenge and that genuine and full involvement is hard to reach. The session will provide a brief overview of peer involvement in Europe, personal examples of recent peer initiatives in Europe and will elaborate how to start and support simular initiatives and collaborations. At the end of the session the website manual will be launched, which was developed during the Correlation II project.

Franz Trautmann and John Peter Kools, Trimbos Institute, Netherlands

 

Skill building II: Social Intervention Tool (Ehealth)
>>> Download pdf
how to reach target groups on the internet – a ready to use tool for service provider
Internet offers unique opportunities for new methods and strategies to do effective online Outreach, using chat. Correlation II has been working on the development of a Social Intervention Tool (SIT).
In the workshop we will introduce the SIT and the first results of our pilot. We will present a brief training in using the tool and guidelines for online outreach. Skills for chatting, differences between online conversations and normal outreach, how to structuralize a chat,
professionalize a team and your message, how to document it and analyse data for research and improvement and more, presented in a Nutshell.
And finally we will unmask our future plans, SIT 2.0, at the end of the workshop!

Chair:
Pjer Vriens, Municipal Health Service, Rotterdam, Netherlands

Speaker:
Antti Ervasti, Kalliola Youth Association, Finland
Nicklas Dennermalm, RFSL Stockholm, Sweden
Alexey Chystotin, SIT Developer, Ukraine
Frank ten Horn, STI AIDS Netherlands, Netherlands

 

Skill building III: Outreach and Early Intervention
Most services for drug user are targeting older injecting users, not suitable for a younger group which is still in a phase of experimentation and not necessarily with problematic drug use. A Correlation II expert group explored new approaches to reach this group by various early intervention strategies.
Chair:
Anniken Sand, Competence Centre Alcohol and Drug Addiction, Norway

  • Young people at risk – methods and approach to work for and with young people
    >>> Download pdf

    Anniken Sand, Competence Centre Alcohol and Drug Addiction, Norway

  • The use of interviews as a method to improve our practice and to involve peers
    Linda Svalsrod, Nordstrand utekontakt, Norway

  • Reaching a new group by systematic outreach and new approaches "EMO-kids at platform 19, Central station"
    >>> Download pdf

    Linda Høgheim, Oslo Outreach Youth Service, Norway

  • Lessons learned from 15 years of delivering peer education he profile of outreach workers – working towards a standard in Europe
    >>> Download pdf
    Andrea Dixon, DISC, United Kingdom

 

Skill building IV: Hepatitis C training manual
Train the trainers for a better Hepatitis C treatment and care

>>> Download pdf

The session provides an introduction to a three day modular training for people, responsible for delivering HCV treatment and care with PWID. The manual was developed in the framework of the Correlation II project and field tested an implemented by different organisationsin 2011. The training introduce HCV, its transmission and prevention, examine the diagnostic tests and treatments that are used and the evidence that underpins these and promotes reflection on some of the key organisational, practice and policy issues that affect the provision of HCV treatment and care.

Chair/speaker:
Danny Morris and Neil Hunt, United Kingdom trainer & consultants

13.00 Lunch
14.30

Abstract driven parallel sessions

 

WS 1: Nothing about us with out us – self organisation and networking
Local and national experiences and the development of an European Drug User Organisation

Chair:
Fabrice Olivet, ASUD, France
Speaker:
Berne Stålenkrantz, SDUU, Sweden
Eliot Albers, INPUD, United Kingdom
Janko Belin, NGO Areal, Slovenia

 

WS 2: Evidence-base versus grass-root? – dilemma's and opportunities for evaluation and monitoring.
>>> Download pdf

The street is not a laboratory. How to achieve the best possible evidence that grass roots interventions work?

Chair/Speaker:
Hans Verbraeck, CVO, Netherlands
Dagmar Hedrich, EMCDDA, Portugal


  WS 3: participation and social enterprises
Chair: Hans Wijnands, Regenboog Groep, Netherlands

The workshop will investigate the oppportunities of involving and integrating marginalised groups on the local labour market. Various organisations will share their experience and discuss innovative approaches.

  • Let's work it out – methods, challenges and fall sticks for client driven social enterprises – models of good practice
    >>> Download pdf

    Brigit Nieuwburg, Regenboog Groep, Netherlands

  • Working First: An experience of reintegration of drug users as peer workers in Portugal
    >>> Download pdf
    Joana Marques, Apdes, Portugal

  • Fix und fertig – The organisation and the impact of working projects in Vienna
    >>> Download pdf
    Walter Wojcik, Verein Wiener Sozialprojekte, Austria

in cooperation with Drogart, Slovenia
 

WS 4: From culturally – sensitive to Community based?
The long way to participatory HIV/STI prevention with and for ethnic communities

The workshop will focus on effective community involvement in HIV/STI prevention of ethnic minorities and migrant groups. Underlying concepts in use Europe wide along the line of participatory approaches (e.g. culturally-sensitive, community-friendly, community-oriented or community-based) will be critically reviewed, presenting the assessment survey results of the BORDERNETwork project. In working groups the participants will share experience related to the key issues of participatory prevention from the perspective of the affected communities: how much participation is enough, what is the minimum standard, what is the good practice standard?
Finally, a presentation of an evidence-based community-based model of prevention (POL) applied in Roma and other marginalized communities in Bulgaria and other Balkan countries will highlight important features of the implementation of participatory HIV/STI prevention in practice.

Speakers:
Elfriede Steffan, SPI Forschung, Germany

Tzvetina Arsova Netzelmann, SPI Forschung, Germany >>> Download pdf
Radostina Antonova, HESED, Bulgaria >>> Download pdf

Workshop organised by the BORDERNET project.

 

5th Slovenian national symposium "Hepatitis C virus infection in drug users"
>> see seperate programme, (Slovenian language)

Chairs:
Mojca Matičič, Clinic for Infectious Diseases, University medical
Centre Ljubljana, Slovenia
Andrej Kastelic, Coordination of Centers for Prevention and Treatment of Drug Addiction, Ljubljana, Slovenia

Co-hosts:
Clinic for Infectious Diseases and Febrile Illnesses,
University Medical Centre Ljubljana, Slovenia and
Coordination of Centers for Prevention and Treatment of Drug Addiction, Ljubljana,Slovenia

16.00 Break
16.30

Workshops and parallel sessions

WS 5: Towards an integrated approach to HIV/AIDS and mental health
Almost all studies that have researched the prevalence of mental health disorder in PLHIV have found considerably higher levels of mental disorder in the infected group than in the general population. While the exact extent of these differences varies across situations it seems that PLHIV are at least twice as likely to have a mental disorder than people who are not affected. Why should it be the case? The workshop on HIV/AIDS and Mental Health will try to give answer to this question and, illustrated by the MAIDS-project, will elaborate on how we can ensure that mental health becomes an integral part of prevention, care and treatment programs in the European region.

Speakers:
Katja Assoian, GIP, Netherlands >>> Download pdf
Annemiek Schadé, GGZinGeest, Netherlands >>> Download pdf
Miran Šolinc, SKUC, Slovenia >>> Download pdf
Artur Lutarewicz, SKA, Poland.

Workshop organised by the MAIDS project

WS 6: Interventions targeting marginalised groups – experiences in Europe
Chair: Jasperine Schupp, Regenboog Groep, Netherlands
abstract driven session

  • Screening for Hepatitis B and C among migrants in the EU
    >>> Download pdf
    Irene Veldhuijzen, HepScreen project, Netherlands

  • Homeless migrants in Copenhagen: experiences and conclusions of a project with rough sleepers
    >>> Download pdf
    Lisette Leth-Andersen, UDENFOR, Denmark

  • Intercultural help with drug addiction empowers cultural minorities
    Ramazan Salman, Aids & Mobility, Germany

  • The care for each other: encouraging peer driven fellow care
    >>> Download pdf
    Jean Paul Grund, Center for Addictology, Charles University Prague, Czech Republic

WS 7: Harm reduction works
Chair:
Maria Phelan, Euro HRN, United Kingdom

abstract driven session

  • Harm reduction in Europe – state of affairs
    European audit on harm reduction in the EU
    >>> Download pdf
    Claudia Stoicescu, EuroHRN
    , United Kingdom

  • From acceptance-orientated to development-orientated harm reduction: 25 years of safe injection rooms in Bern
    >>> Download pdf
    Jakob Huber, Contact Netz, Switzerland

  • PROWfile – The profile of outreach workers in harm reduction – working towards a standard in Europe
    >>> Download pdf
    Sofia Maia, Apdes, Portugal

  • Drugs, prison and harm reduction
    >>> Download pdf
    Eka Iakobishvili, United Kingdom

WS 8: Hepatitis and drug use
Chair: Jason Farrell, NL

  • working in partnership: Challenges and innovations in HCV treatment for people who inject drugs
    >>> Download pdf
    Magdalena Harris, United Kingdom

  • Innovative approaches for preventing infection with hepatitis C among drug users
    >>> Download pdf
    Astrid Leicht, Fixpunkt, Germany

  • HCV treatment regional advocacy in Eastern Europe
    >>> Download pdf
    Dasha Ocheret, EHRN, Lithuania
 
 

Satellite:
Challenges for prevention in South East Europe
Exchange of best practices and discussion on successful examples of prevention projects. Strategies to improve the effectiveness of prevention activities in the countries of the SEE region.

Chair:
Thanasis Apostolou, Diogenis Association, Greece
Speaker:
Svetlana Vojnovska, Healthy Options Project Skopje (HOPS), Macedonia
Dejan Travica, Udruga Terra, Croatia
Tatjana Preradovic- Sjenica, Viktorija, Bosnia Herzegovina
Theodoros Gigelopoulos, Organisation Against Drugs (OKANA), Greece
>>> Download pdf

Workshop organised by the Drug Policy Network in SEE

18.00 End

Wednesday, 14 December 2011
9.30

Major session I:

Developing new addiction treatment and harm reduction programmes in communities and prisons in South Eastern Europe

Chairs:
Franz Trautmann, Trimbos Institute, Netherlands
Andrej Kastelic, South Eastern Adriatic Addiction Treatment Network (SEEAnet)

  • Introduction
    There are some models of comprehensive care that are able to take advantages of potential interfaces between drug users and the health care system through primary care or specialized drug treatment programs and other community services from harm reduction programs to drug free programs and programs in custodial settings.
    No single model is sufficient in any given environment. The most important goals of appropriate treatment for the individuals are to stay alive, achieve abstinence or a stabilized use, stabilize social live, improve physical health and reduce criminal activity. The most important effectiveness for society is to improve public health, reduce emergencies, hospitalisations, reduce spread of HIV and other infectious diseases, reduce social welfare costs and reduce costs in criminal justice system.
    Presented programs from South Eastern Europe might set as an example of a successful practice in line with United Nations recommendations.

    Andrej Kastelic, SEEAnet


  • How to treat drug using youngsters: the under treated vulnerable population
    >>> Download pdf
    Liljana Ignjatova, Psychiatric Hospital Skopje, Macedonia


  • Treating drug users with complex needs (comorbidities) in integrated settings
    Nusa Segrec, Centre for Treatment of Drug Addiction at Psychiatric Clinic Ljubljana, Slovenia


 

Major session II

Sex Work Dialogue session

The discussion will focus on the consequences for provider of harm reduction when operating under different legislations and policies on sex work. In this panel you will hear views from different stakeholders, ranging from politics and academia to service provision ands sex worker rights.

Chair:
Pye Jakobsson, Rose Alliance
, Sweden
Speakers:
Jay Levy, University of Cambridge, United Kingdom >>> Download pdf
Pia Covre, sex worker activist and politician, Italy >>> Download pdf
Marianne Jonker, sex worker activist, Netherlands >>> Download pdf
Jaana Kauppinen, Pro Tukipiste, Finland >>> Download pdf

11.00 Break
11.30

Final plenary session:
Drug Policy Reform – from evidence to practice

The session will provide the current evidence on the need for drug policy reform and discuss the proposals of the report of the Global Commission on Drug Policy('Wat on Drugs, June 2011) with the view to explore strategies and actions for change.

The session will bring together policy makers, service providers, and representatives from affected communities.

Chair and Introduction:
Thanasis Apostolou, Diogenis Association

Research:

  • Martin Jelsma, Transnational Institute, Netherlands

Policy makers:

  • Jindřich Vobořil, drug coordinator Czech Republic
  • Meni Malliori, Drug coordinator Greece >>> Download pdf
  • On behalf of Global Commission on Drug Policy and Global Fund: Ann Fordham, IDPC

Civil Society:

13.00 Conclusions and greetings
Correlation Team